Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)
- Conditions
- Prostate Cancer
- Interventions
- Other: Observation
- First Posted Date
- 2022-06-21
- Last Posted Date
- 2022-06-24
- Lead Sponsor
- BioProtect
- Target Recruit Count
- 19
- Registration Number
- NCT05423431
- Locations
- 🇺🇸
Advanced Radiation Centers of New York ("ARC"), Lake Success, New York, United States
Post Marketing Clinical Follow Up of the BioProtect Balloon Implant System
- Conditions
- Prostate Cancer
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- BioProtect
- Target Recruit Count
- 80
- Registration Number
- NCT05354440
- Locations
- 🇮🇱
Assuta Ashdod medical center, Ashdod, Israel
🇮🇱Rabin Medical Center, Petah Tikva, Israel
🇳🇱Maastricht radiation oncology, Maastricht, Netherlands
Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients
- Conditions
- Prostate Cancer
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2022-05-20
- Lead Sponsor
- BioProtect
- Target Recruit Count
- 175
- Registration Number
- NCT05354427
- Locations
- 🇵🇹
Cuf Porto institution, Porto, Portugal
🇵🇱Institute of Maria Skłodowska, Curie (MCMCC), Warsaw, Poland
Prospective Evaluation of a Commercially Available Hydrogel Spacer
- Conditions
- Prostate Cancer
- Interventions
- Other: Observation
- First Posted Date
- 2022-04-12
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- BioProtect
- Target Recruit Count
- 20
- Registration Number
- NCT05323747
- Locations
- 🇺🇸
Western Radiation Oncology, Campbell, California, United States
🇺🇸Northern Nevada Radiation Oncology, Reno, Nevada, United States
BioProtect Balloon Implantâ„¢ Balloon System Pivotal Study BP-007
- Conditions
- Prostate Cancer
- Interventions
- Device: ProSpaceOther: Control
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- BioProtect
- Target Recruit Count
- 222
- Registration Number
- NCT03400150
- Locations
- 🇵🇱
Institute of Maria Skłodowska-Oncology Centre, Warsaw, Poland
🇺🇸New York University Langone Health, New York, New York, United States
🇬🇧Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
Pilot Study to Assess the Safety and Efficacy of BioProtect Balloon in Prostate Cancer Subjects
- Conditions
- Prostate Cancer
- Interventions
- Device: balloon implantProcedure: Balloon implantation
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2018-11-20
- Lead Sponsor
- BioProtect
- Target Recruit Count
- 24
- Registration Number
- NCT00918229
- Locations
- 🇺🇸
Virginia Commonwealth University School of Medicine, Massey Cancer Center, Richmond, Virginia, United States
Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing Radiotherapy
- Conditions
- Prostate Cancer
- Interventions
- Device: Absorbable perirectal spacer
- First Posted Date
- 2007-04-18
- Last Posted Date
- 2019-08-08
- Lead Sponsor
- BioProtect
- Target Recruit Count
- 7
- Registration Number
- NCT00462124
- Locations
- 🇮🇱
Ichilov Medical Center, Tel Aviv, Israel